PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2848549-1	1988	Peripheral-type benzodiazepine binding of [3H]Ro5-4864 at one, non-saturating concentration and activities of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) were measured in 7 cortical areas from postmortem brains of 18 patients with Alzheimer disease (AD), 12 age-matched controls, and 15 miscellaneous neurological cases.	Benzodiazepines	16-30	acetylcholinesterase (Cartwright blood group)	Homo sapiens	147-167	
2848549-1	1988	Peripheral-type benzodiazepine binding of [3H]Ro5-4864 at one, non-saturating concentration and activities of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) were measured in 7 cortical areas from postmortem brains of 18 patients with Alzheimer disease (AD), 12 age-matched controls, and 15 miscellaneous neurological cases.	Benzodiazepines	16-30	acetylcholinesterase (Cartwright blood group)	Homo sapiens	169-173	
24774720-0	2014	Rapid detoxification of benzodiazepine or Z-drugs dependence using acetylcholinesterase inhibitors.	Benzodiazepines	24-38	acetylcholinesterase (Cartwright blood group)	Homo sapiens	67-87	
24774720-4	2014	Acetylcholinesterase inhibitors have been shown to reverse BZDs induced sedation.	Benzodiazepines	59-63	acetylcholinesterase (Cartwright blood group)	Homo sapiens	0-20	
24774720-5	2014	We propose that oral form acetylcholinesterase inhibitors (donepezil, galantamine and rivastigmine) also posses the effect of inhibiting GABA receptors, and act as indirect antagonist, to be applied in the rapid detoxification treatment of BZDs and Z-drug dependence.	Benzodiazepines	240-244	acetylcholinesterase (Cartwright blood group)	Homo sapiens	26-46